Your browser doesn't support javascript.
loading
Safety and efficacy of hematopoietic and mesanchymal stem cell therapy for treatment of T1DM: a systematic review and meta-analysis protocol.
Madani, Sedigheh; Larijani, Bagher; Keshtkar, Abbas Ali; Tootee, Ali.
Afiliação
  • Madani S; Endocrinology and Metabolism Research Institute, Tehran University of Medical Science, Tehran, Iran.
  • Larijani B; Endocrinology and Metabolism Research Institute, Tehran University of Medical Science, Tehran, Iran. EMRC@tums.ac.ir.
  • Keshtkar AA; Tehran University of Medical Science, Tehran, Iran.
  • Tootee A; Endocrinology and Metabolism Research Institute, Tehran University of Medical Science, Tehran, Iran.
Syst Rev ; 7(1): 23, 2018 01 26.
Article em En | MEDLINE | ID: mdl-29373983
ABSTRACT

INTRODUCTION:

Insulin standard treatment of T1DM cannot cure the patients as different chronic complications occurred subsequently. Investigations on a curative treatment in T1DM propose cell replacement or maintenance instead of exogenous insulin therapy, but different dimensions of this novel treatment are not clarified. METHODS AND

ANALYSIS:

We will include all clinical trials which have evaluated the efficacy MSC or HSC transplantation in T1DM treatment; electronically search bibliographic databases, country registration data banks, and gray literatures; and hand-search two key journals, two experts' article, and references of the included articles with no language restriction. Primary outcome is the extent of reduction in insulin requirement and secondary outcomes are safety of MSC and HSC therapy, effect of this therapy on diabetic parameters, effect of the rout of transplantation and origin of the MSC or HSC on efficacy of treatment, studies heterogeneity and potential reasons of it. Heterogeneity and its severity will be calculated with Q Cochrane test, P value, and I2 index. STATA software version 12 will be used for meta-analysis. PROSPERO Registration number CRD42016047176. ETHICS AND DISSEMINATION We will publish the systematic review in a peer review journal; as it presents an analysis of published literature, the study does not require ethical approval. STRENGTHS AND LIMITATIONS OF THIS STUDY This systematic review and meta-analysis will investigate the efficacy of MSC and HSC transplantation in T1DM treatment with no language restriction. Also we will evaluate gray literatures after hand searching. This protocol is prepared according to Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P). Two reviewers will evaluate screened full texts, extract data, and asses risk of bias of eligible primary studies independently. As there is the possibility that we miss some unpublished primary studies due to negative results, we will use funnel plot to detect this and correct it with fill and trim method.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco Mesenquimais / Diabetes Mellitus Tipo 1 / Segurança do Paciente Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco Mesenquimais / Diabetes Mellitus Tipo 1 / Segurança do Paciente Idioma: En Ano de publicação: 2018 Tipo de documento: Article